000			01931 a2200565 4500
005			20250515225845.0
264		0	_c20110804
008			201108s 0 0 eng d
022			_a1476-5365
024	7		_a10.1038/bmt.2010.137 _2doi
040			_aNLM _beng _cNLM
100	1		_aCantoni, N
245	0	0	_aOrder of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT. _h[electronic resource]
260			_bBone marrow transplantation _cMar 2011
300			_a344-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aBusulfan _xadministration & dosage
650	0	4	_aChemical and Drug Induced Liver Injury _xetiology
650	0	4	_aCohort Studies
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aGraft vs Host Disease _ximmunology
650	0	4	_aHematopoietic Stem Cell Transplantation _xadverse effects
650	0	4	_aHepatic Veno-Occlusive Disease _xchemically induced
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aLiver _xdrug effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aRetrospective Studies
650	0	4	_aTransplantation Conditioning _xadverse effects
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aGerull, S
700	1		_aHeim, D
700	1		_aHalter, J
700	1		_aBucher, C
700	1		_aBuser, A
700	1		_aTsakiris, D A
700	1		_aPassweg, J
700	1		_aTichelli, A
700	1		_aStern, M
700	1		_aGratwohl, A
773	0		_tBone marrow transplantation _gvol. 46 _gno. 3 _gp. 344-9
856	4	0	_uhttps://doi.org/10.1038/bmt.2010.137 _zAvailable from publisher's website
999			_c19897789 _d19897789